Education
About Us
Working with TipRanks
Follow Us
Telo Genomics (TSE:TELO)
:TELO
RESEARCH TOOLSreports
TELO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.09 - C$0.23
Previous CloseN/A
Volume60.50K
Average Volume (3M)14.68K
Market Cap
C$9.98M
Enterprise ValueN/A
Total Cash (Recent Filing)C$2.25M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.32
Next Earnings
Jun 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding99,811,180
10 Day Avg. Volume27,650
30 Day Avg. Volume14,680
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Telo Genomics Corp News
PremiumCompany Announcements
Telo Genomics’ MRD Data in Multiple Myeloma Gains ASCO Recognition
PremiumCompany Announcements
Telo Genomics Strengthens Leadership with New Board Appointment
PremiumCompany Announcements
Telo Genomics Strengthens Leadership with New Executive Chairman
PremiumCompany Announcements
Telo Genomics Secures $2.5 Million in Oversubscribed Placement
PremiumCompany Announcements
Telo Genomics Approved for Ontario IP Support
PremiumCompany Announcements
Telo Genomics Broadens Partnership with Mayo Clinic
PremiumCompany Announcements
Telo Genomics Unveils Promising Myeloma Test Results---
Options Prices
Currently, No data available
---
Ownership Overview
0.15% Insiders
―
Mutual Funds
― Other Institutional Investors
99.85% Public Companies and
Individual Investors
TELO FAQ
What was Telo Genomics’s price range in the past 12 months?
Telo Genomics lowest stock price was C$0.09 and its highest was C$0.23 in the past 12 months.
What is Telo Genomics’s market cap?
Telo Genomics’s market cap is C$9.98M.
When is Telo Genomics’s upcoming earnings report date?
Telo Genomics’s upcoming earnings report date is Jun 03, 2025 which is in 53 days.
How were Telo Genomics’s earnings last quarter?
Telo Genomics released its earnings results on Feb 26, 2025. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
Is Telo Genomics overvalued?
According to Wall Street analysts Telo Genomics’s price is currently Overvalued.
Does Telo Genomics pay dividends?
Telo Genomics does not currently pay dividends.
What is Telo Genomics’s EPS estimate?
Telo Genomics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Telo Genomics have?
Telo Genomics has 99,811,180 shares outstanding.
What happened to Telo Genomics’s price movement after its last earnings report?
Telo Genomics reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 20%.
Which hedge fund is a major shareholder of Telo Genomics?
Currently, no hedge funds are holding shares in TSE:TELO
---
Company Description
Telo Genomics
Telo Genomics Corp (TELO) is a biotechnology company specializing in the development and commercialization of innovative genetic testing services. Operating primarily in the healthcare sector, Telo Genomics focuses on leveraging its proprietary technology, TeloView, to provide advanced genomic solutions that assist in the management and treatment of cancer and other diseases. The company's core offerings include diagnostic and prognostic tests designed to enhance patient care through early detection and personalized medicine.
---
Technical Analysis
---